While leaders of both political parties say they want to provide Medicare patients with meaningful coverage for prescription drug expenses, major philosophical differences threaten to make that objective extremely difficult to achieve.
New Dermatology Social Comparison Scale Demonstrates Acceptable Psychometrics for Clinical and Research Applications
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
A Novel Approach to Distinguishing Scabies From Atopic Dermatitis
ReV Up Your Vitiligo Treatment Strategies
In Interim Analysis, Mogamulizumab Demonstrates Improvements In Mycosis Fungoides, Sézary Syndrome
FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know